TYRP1 and cutaneous melanoma: The prevalence of TYRP1 expression (>1%) in cutaneous melanoma observed in this study was in the same range as the prevalence in metastatic cutaneous melanoma samples from an in-house internal tissue bank (n = 51), analyzed with the Ventana EPR13063 investigational IHC assay (70% vs 66%).